サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1287627

不妊治療薬市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
不妊治療薬市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の不妊治療薬の市場規模は、2022年に38億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.24%の成長率（CAGR）を示し、2028年までに52億米ドルに達すると予測しています。

不妊治療薬とは、不妊症の治療や個人の生殖機能を高めるために使用される様々な薬剤を指します。不妊治療薬は、注射や経口投与で使用されます。一般的に使用される不妊治療薬には、ゴナドトロフィン、アロマターゼ阻害剤、選択的エストロゲン受容体モジュレーター（SERM）、ビグアナイド、排卵促進剤、ドーパミンアゴニスト、三環系抗うつ剤などがあります。これらは、女性では卵巣の排卵や卵胞の発育を促すことで効果を発揮し、一方、男性ではテストステロン値の回復や精子の質を向上させることで妊娠につなげます。近年、不妊治療薬は、妊娠できない夫婦の間で支持されています。

不妊治療薬の市場動向：

不妊治療薬は、妊娠に貢献する個人の能力を回復させることで、カップルの妊娠の可能性を高めることを支援します。その結果、不妊症や流産が増加し、市場の成長を促す主な要因となっています。このほか、利用可能な治療法に関する認識を広めるために各国政府が行ったいくつかの有利な取り組みが、不妊治療薬の需要を喚起しています。さらに、多忙な勤務体系やそれに伴うストレス、ライフスタイルの変化により、がん、肥満、糖尿病、甲状腺、多嚢胞性卵巣症候群（PCOS）、更年期障害などの慢性疾患の有病率が大幅に上昇しています。また、妊娠の遅れや晩婚化、アルコールや薬物の過剰摂取、喫煙などの不健康な生活習慣による出生率の低下が、製品の普及率を加速しています。さらに、複数の主な企業が研究開発活動に取り組み、より高い有効性、より少ない投与量、より少ない副作用を持つ革新的な不妊治療薬を発売しています。さらに、不妊治療薬開発のための公的資金の増加や、さまざまな規制機関からの迅速な医薬品承認が、市場の成長を後押ししています。その他、ジェネリック医薬品の需要の高まり、ヘルスケアインフラの改善、消費者支出の増加、急速な都市化、技術の進歩なども、市場成長にプラスの影響を与えています。

本レポートで回答した主な質問

  • 不妊治療薬の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのでしょうか？
  • COVID-19は世界の不妊治療薬市場にどのような影響を与えたか？
  • 主要な地域市場とは？
  • 薬剤クラスに基づく市場の内訳は？
  • 投与経路に基づく市場内訳は？
  • 流通チャネルに基づく市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々なステージは何か？
  • 業界における主要な促進要因と課題は何か？
  • 世界の不妊治療薬の市場構造と主要プレイヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 不妊治療薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 薬剤クラス別市場内訳

  • ゴナドトロピン
    • 市場動向
    • 市場予測
  • アロマターゼインヒビター
    • 市場動向
    • 市場予測
  • 選択的エストロゲン受容体モジュレーター（SERMs）
    • 市場動向
    • 市場予測
  • ビグアナイド系
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 投与経路別市場内訳

  • 経口
    • 市場動向
    • 市場予測
  • 静脈内
    • 市場動向
    • 市場予測
  • 皮下注射
    • 市場動向
    • 市場予測
  • 筋肉内
    • 市場動向
    • 市場予測

第8章 流通チャネル別市場内訳

  • 病院内薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 エンドユーザー別市場内訳

  • 男性
    • 市場動向
    • 市場予測
  • 女性
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会（Opportunities
  • 脅威（Treats

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Theramex
図表

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players
目次
Product Code: SR1623A385_Report

The global infertility drugs market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.24% during 2023-2028.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Others

Breakup by Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by End User:

Male

Female

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:

  • How has the global infertility drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Infertility Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Route of Administration

  • 7.1  Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Livzon Pharmaceutical Group Inc. 
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6  Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7  Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8  Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10  Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio